Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Inventory Average (2023 - 2026)

Indivior Pharmaceuticals has reported Inventory Average over the past 4 years, most recently at $152.5 million for Q1 2026.

  • For Q1 2026, Inventory Average fell 7.58% year-over-year to $152.5 million; the TTM value through Mar 2026 reached $152.5 million, down 7.58%, while the annual FY2025 figure was $160.0 million, 9.22% up from the prior year.
  • Inventory Average for Q1 2026 was $152.5 million at Indivior Pharmaceuticals, down from $154.0 million in the prior quarter.
  • Over five years, Inventory Average peaked at $174.5 million in Q3 2024 and troughed at $134.0 million in Q4 2023.
  • A 4-year average of $155.3 million and a median of $154.0 million in 2025 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: increased 28.73% in 2024 and later decreased 12.89% in 2025.
  • Year by year, Inventory Average stood at $134.0 million in 2023, then increased by 28.73% to $172.5 million in 2024, then dropped by 10.72% to $154.0 million in 2025, then dropped by 0.97% to $152.5 million in 2026.
  • Business Quant data shows Inventory Average for INDV at $152.5 million in Q1 2026, $154.0 million in Q4 2025, and $152.0 million in Q3 2025.